• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    Funders commit to COVID-19 vaccine access but US opts out

    WHO launched the COV-Access Agreement on Friday, signed by 25 key players — though one was notably absent.

    By William Worley, Michael Igoe // 28 April 2020
    A vial of the COVID-19 vaccine candidate to be used in Phase 1 clinical trial at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain. Picture taken April 2, 2020. Photo by: Sean Elias / Reuters

    LONDON/WASHINGTON — Twenty-five key players are pledging to make new vaccines and treatments for COVID-19 accessible around the world, following concerns that access for lower-income countries might not be prioritized.

    The COV-Access Agreement, launched virtually by the World Health Organization on Friday, commits countries to a cooperative international response to the pandemic and “equitable global access to innovative tools for COVID-19 for all.”

    COVID-19 — a timeline of the coronavirus outbreak

    Follow the latest developments on the new coronavirus that causes COVID-19.

    Leading funders including the U.K., France, Germany, the European Commission, the World Bank, and the Bill & Melinda Gates Foundation signed the pledge, alongside Gavi, the Global Fund, and the International Federation of Pharmaceutical Manufacturers.

    But the U.S. — the world’s biggest bilateral donor, which recently suspended funding to WHO — was conspicuously absent from the agreement, which health experts said was “concerning.”

    “There will be no U.S. official participation,” a spokesperson for the country’s mission in Geneva confirmed to Reuters.

    Alongside equitable global access, the agreement also commits to an “unprecedented level” of international coordination and research cooperation, collective decision-making on coronavirus responses, and accountability “to the world.”

    The U.K. — which has been a leading donor to coronavirus research — took credit for helping to organize the pledge, saying the agreement followed “continued international lobbying from the UK for more global co-operation on the pandemic,” including at meetings of the G-20 and World Bank. On May 4, the country will co-host a virtual Coronavirus Global Response Summit, which aims to raise £7 billion ($8.7 billion) for diagnostics, vaccines, and treatments.

    “It would be a tragedy if the US absence from this global effort means ... that the countries where US global health has invested for decades miss out on the full benefit.”

    — Amanda Glassman, executive vice president, Center for Global Development

    Experts criticized the U.S. decision not to participate in the pledge and suggested it could have been based on WHO’s involvement. Amanda Glassman, executive vice president at the Center for Global Development think tank, told Devex via email: "As the US is by far the largest funder in global health, its absence from an initiative organized by one of our closest allies (UK) is troubling.

    “A vaccine or treatment may be developed anywhere in the world — it would be a tragedy if the US absence from this global effort means ... that the countries where US global health has invested for decades miss out on the full benefit.”

    Dr. Kate Tulenko, CEO of Corvus Health, a health care consulting company, agreed that “it is very concerning that the U.S. has not signed this agreement” given its “outsized role” in vaccine development. She noted that the HPV and pneumococcal vaccines — the last two additions to the international set of vaccines — were both developed with significant U.S. involvement.

    However, she suggested the move could be a play to get countries such as India and China to invest more in health or to appease parts of the government’s voter base.

    “Despite how distressing this is, I think this action is not a sign that the U.S. will reduce its investments in vaccine development and availability,” she said.

    WHO has also appointed two special envoys on vaccine research and equity: Sir Andrew Witty, former chief executive at GlaxoSmithKline, and Ngozi Okonjo-Iweala, a Gavi board member.

    Visit our dedicated COVID-19 page for news, job opportunities, and funding insights.

    • Funding
    • Global Health
    • WHO
    • United States
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the authors

    • William Worley

      William Worley@willrworley

      Will Worley is the Climate Correspondent for Devex, covering the intersection of development and climate change. He previously worked as UK Correspondent, reporting on the FCDO and British aid policy during a time of seismic reforms. Will’s extensive reporting on the UK aid cuts saw him shortlisted for ‘Specialist Journalist of the Year’ in 2021 by the British Journalism Awards. He can be reached at william.worley@devex.com.
    • Michael Igoe

      Michael Igoe@AlterIgoe

      Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.

    Search for articles

    Related Stories

    Global HealthOpinion: Ensuring oxygen access is essential to achieving health for all

    Opinion: Ensuring oxygen access is essential to achieving health for all

    Global HealthGavi pledges fall short about $2.9B as US pulls out

    Gavi pledges fall short about $2.9B as US pulls out

    Devex CheckUpDevex CheckUp: Exempted or not? Trump’s orders spark confusion

    Devex CheckUp: Exempted or not? Trump’s orders spark confusion

    Pandemic preparednessOpinion: Failing to finalize a pandemic agreement is not an option

    Opinion: Failing to finalize a pandemic agreement is not an option

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 3
      Opinion: India’s bold leadership in turning the tide for TB
    • 4
      USAID's humanitarian bureau is under pressure and overstretched
    • 5
      WHO names new directors in ongoing restructure
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement